Evidence map›Paper›PMID 36837699›Full record

ArticleMembranes2023

Binding of Different Cyclosporin Variants to Micelles Evidenced by NMR and MD Simulations.

Polina P Kobchikova, Sergey V Efimov, Vladimir V Klochkov

Open access · goldAbstract read
In one paragraph

Article in Membranes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Interaction of Cyclosporin C with DyInternational journal of molecular sciences · 2024
    Article
  2. Berberine-styrene-RSC advances · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Polina P KobchikovaInstitute of Physics, Kazan Federal University, 18 Kremlevskaya, 420008 Kazan, Russia.ORCID 0000-0003-0223-8656
Sergey V EfimovInstitute of Physics, Kazan Federal University, 18 Kremlevskaya, 420008 Kazan, Russia.ORCID 0000-0002-9918-8124
Vladimir V KlochkovInstitute of Physics, Kazan Federal University, 18 Kremlevskaya, 420008 Kazan, Russia.ORCID 0000-0001-7366-5116
Kazan Federal University · RU

Funding

Ministry of Science and Higher Education of the Russian Federation State assignment in the sphere of scientific activities no. 0671-2020-0051.
6 · The paper itself

Abstract

Peptides play a critical role in the life of organisms, performing completely different functions. The biological activity of some peptides, such as cyclosporins, can be determined by the degree of membrane permeability. Thus, it becomes important to study how the molecule interacts with lipid bilayers. Cyclosporins C, E, H and L were characterised molecular dynamics simulation; NMR spectroscopy studies were also carried out for cyclosporins C and E. The comparison of one- and two-dimensional spectra revealed certain similarities between spatial structures of the studied cyclosporin variants. Upon dissolving in water containing DPC micelles, which serve as model membranes, subtle changes in the NMR spectra appear, but in a different way for different cyclosporins. In order to understand whether observed changes are related to any structural modifications, simulation of the interaction of the peptide with the phospholipid micelle was performed. The onset of the interaction was observed, when the peptide is trapped to the surface of the micelle. Simulations of this kind are also of interest in the light of the well-known membrane permeability of cyclosporin, which is important for its biological action.

Indexed as

cyclosporinmicellemolecular dynamicsNMR

Identifiers

PMID36837699
PMCPMC9965255
OpenAlexW4319318525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.